BIOMAT Database Logo BIOMAT Database Logo

Review of regional limb perfusion with melphalan for malignant melanoma. 1966

W T Irvine, and R J Luck

UI MeSH Term Description Entries
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008558 Melphalan An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen. Medphalan,Merphalan,Phenylalanine Mustard,Sarcolysine,Sarkolysin,4-(Bis(2-chloroethyl)amino)phenylalanine,Alkeran,L-PAM,Mustard, Phenylalanine
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010478 Chemotherapy, Cancer, Regional Perfusion Neoplasm drug therapy involving an extracorporeal circuit with temporary exclusion of the tumor-bearing area from the general circulation during which high concentrations of the drug are perfused to the isolated part. Cancer Chemotherapy, Regional Perfusion,Perfusion Cancer Chemotherapy, Regional,Regional Perfusion Antineoplastic Chemotherapy,Isolation Perfusion Cancer Chemotherapy,Regional Perfusion Cancer Chemotherapy
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D005263 Femoral Artery The main artery of the thigh, a continuation of the external iliac artery. Common Femoral Artery,Arteries, Common Femoral,Arteries, Femoral,Artery, Common Femoral,Artery, Femoral,Common Femoral Arteries,Femoral Arteries,Femoral Arteries, Common,Femoral Artery, Common

Related Publications

W T Irvine, and R J Luck
Isolated limb perfusion with melphalan for melanoma.
March 2014, Journal of surgical oncology,
W T Irvine, and R J Luck
The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanoma.
July 1992, British journal of cancer,
W T Irvine, and R J Luck
Isolated limb perfusion with melphalan in the treatment of malignant melanoma.
September 1980, The British journal of surgery,
W T Irvine, and R J Luck
Isolated hyperthermic perfusion with mitoxantrone of melphalan in malignant melanoma of the limb.
October 1995, American journal of surgery,
W T Irvine, and R J Luck
Regional perfusion treatment with melphalan for melanoma in a limb: an evaluation of drug kinetics.
April 1988, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
W T Irvine, and R J Luck
Anaesthetic experience with isolated limb perfusion with melphalan for melanoma.
September 1996, Perfusion,
W T Irvine, and R J Luck
Isolated limb perfusion for in-transit melanoma metastases: melphalan or TNF-melphalan perfusion?
March 2014, Journal of surgical oncology,
W T Irvine, and R J Luck
Regional isolated perfusion with melphalan for patients with subungual melanoma.
February 1993, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
W T Irvine, and R J Luck
[Isolated hyperthermic limb perfusion with melphalan and tumor necrosis factor in malignant melanoma].
February 1997, Deutsche medizinische Wochenschrift (1946),
W T Irvine, and R J Luck
Systemic toxicity after isolated limb perfusion with melphalan for melanoma.
October 1996, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Copied contents to your clipboard!